Hosted on MSN
Vertex Pharma Stock’s Retail Buzz Intensifies As 2025 Revenue View Lift Fails To Offset Q1 Miss
Retail sentiment surrounding Vertex Pharmaceuticals Inc. (VRTX) surged on Monday, as message volume on Stocktwits spiked 4,100% following the company’s raised 2025 revenue forecast, despite missing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback